Abstract Details

Title Inhibition of FGFR1/2 decreases oligodendrocyte proliferation through ERK signaling in vitro

Topic Multiple Sclerosis

Presentation(s) P1 - (-)

Poster/Presentation
Number 398

Background

Objective

Design/Methods

Results

Conclusions

Authors/Disclosures
Vinothkumar Rajendran (Justus-Liebig University) PRESENTER	Mr. Rajendran has nothing to disclose.
Ranjithkumar Rajendran (Justus Liebig University)	Mr. Rajendran has nothing to disclose.
Martin Berghoff, MD, FAAN (Klinikum Main-Spessart)	Dr. Berghoff has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen Idec. Dr. Berghoff has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Berghoff has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Berghoff has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MerckSerono. Dr. Berghoff has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb.